Macroview Investment Management LLC Intercept Pharmaceuticals, Inc. Transaction History

Macroview Investment Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 03, 2021	SELL	$19.33 - $37.75 $2,648 - $5,171	-137 Closed	0 $0
Q4 2020 Jan 29, 2021	BUY	$24.48 - $42.47 $1,640 - $2,845	67 Added 95.71%	137 $3,000
Q3 2020 Oct 23, 2020	BUY	$39.09 - $53.44 $39 - $53	1 Added 1.45%	70 $3,000
Q2 2020 Aug 11, 2020	BUY	$46.7 - $92.04 $3,222 - $6,350	69 New	69 $3,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Macroview Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Macroview Investment Management LLC with notifications on news.